Published in Hepatology on June 01, 1989
Improving prognosis following a first variceal haemorrhage over four decades. Gut (2001) 2.14
Improved prognosis of cirrhosis patients with esophageal varices and thrombocytopenia treated by endoscopic variceal ligation plus partial splenic embolization. Dig Dis Sci (2006) 1.50
Why portal hypertensive varices bleed and bleed: a hypothesis. Gut (1995) 1.10
Factors related to early mortality in cirrhotic patients bleeding from varices and treated by urgent sclerotherapy. Gut (1992) 0.89
Evaluation of endoscopic variceal ligation (EVL) versus propanolol plus isosorbide mononitrate/nadolol (ISMN) in the prevention of variceal rebleeding: comparison of cirrhotic and noncirrhotic patients. Dig Dis Sci (2005) 0.87
Clinical Management of Chronic Portal/Mesenteric Vein Thrombosis: The Surgeon's Point of View. Viszeralmedizin (2014) 0.86
Transjugular intrahepatic portosystemic shunt. Clin Liver Dis (2014) 0.84
Acute variceal bleeding: general management. World J Gastroenterol (2001) 0.81
Liver transplantation in a randomized controlled trial of emergency treatment of acutely bleeding esophageal varices in cirrhosis. Transplant Proc (2010) 0.81
Epistaxis: an overlooked cause of massive haematemesis in cirrhosis. BMJ (2003) 0.80
Is portal-systemic shunt worthwhile in Child's class C cirrhosis? Long-term results of emergency shunt in 94 patients with bleeding varices. Ann Surg (1992) 0.80
Adjusted blood requirement index as indicator of failure to control acute variceal bleeding. Croat Med J (2006) 0.79
Emergency portacaval shunt versus rescue portacaval shunt in a randomized controlled trial of emergency treatment of acutely bleeding esophageal varices in cirrhosis--part 3. J Gastrointest Surg (2010) 0.78
Risk factors for early rebleeding and mortality in acute variceal hemorrhage. World J Gastroenterol (2014) 0.77
Upper gastrointestinal bleeding from duodenal vascular ectasia in a patient with cirrhosis. World J Gastroenterol (2007) 0.77
A prospective randomized controlled clinical trial comparing the effects of somatostatin and vasopressin for control of acute variceal bleeding in the patients with liver cirrhosis. Korean J Intern Med (2003) 0.75
Determination of correlation of Adjusted Blood Requirement Index with outcome in patients presenting with acute variceal bleeding. World J Gastroenterol (2009) 0.75
Management of digestive bleeding related to portal hypertension in cirrhotic patients: A French multicenter cross-sectional practice survey. World J Gastroenterol (2006) 0.75
Acute management of bleeding oesophageal varices. Drugs (1992) 0.75
CD4+ count-guided interruption of antiretroviral treatment. N Engl J Med (2006) 22.76
Why do people sue doctors? A study of patients and relatives taking legal action. Lancet (1994) 10.79
European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr (2012) 10.61
Computer aided diagnosis of acute abdominal pain: a multicentre study. Br Med J (Clin Res Ed) (1986) 5.49
Two Cases of Thromboembolic Disease Associated with Oral Contraceptives. Br Med J (1962) 4.49
Interleukin-2 therapy in patients with HIV infection. N Engl J Med (2009) 4.38
COX 2 inhibitor and fulminant hepatic failure. Lancet (1999) 3.80
Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy: a randomized trial. Ann Intern Med (2008) 3.68
The critical attitude in medicine: the need for a new ethics. Br Med J (Clin Res Ed) (1984) 3.41
Detection of vancomycin resistance in Enterococcus species. J Clin Microbiol (1992) 3.30
The relation between baseline HIV drug resistance and response to antiretroviral therapy: re-analysis of retrospective and prospective studies using a standardized data analysis plan. Antivir Ther (2000) 3.14
Late presentation of HIV infection: a consensus definition. HIV Med (2011) 2.67
Hepatitis C virus genotypes: an investigation of type-specific differences in geographic origin and disease. Hepatology (1994) 2.60
Migration and geographic variations in blood pressure in Britain. BMJ (1990) 2.55
Aggregative adherence fimbria II, a second fimbrial antigen mediating aggregative adherence in enteroaggregative Escherichia coli. Infect Immun (1997) 2.50
Anti-tuberculosis medication and the liver: dangers and recommendations in management. Eur Respir J (1995) 2.39
Human Gene Mutation Database: towards a comprehensive central mutation database. J Med Genet (2008) 2.37
Intestinal factors in the control of insulin secretion. J Clin Endocrinol Metab (1965) 2.32
Factors associated with a reduced CD4 lymphocyte count response to HAART despite full viral suppression in the EuroSIDA study. HIV Med (2003) 2.30
Cows' milk-sensitive enteropathy. Arch Dis Child (1978) 2.22
Postpartum coma. Lancet (1998) 2.07
High morbidity expected from cirrhosis in injecting drug users. Ir Med J (2004) 2.03
Randomized, double-blind, placebo-controlled trial of somatostatin for variceal bleeding. Emergency control and prevention of early variceal rebleeding. Gastroenterology (1990) 2.02
Can ultrasound probes and coupling gel be a source of nosocomial infection in patients undergoing sonography? An in vivo and in vitro study. AJR Am J Roentgenol (1995) 1.97
British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy. HIV Med (2003) 1.94
Hepatotoxicity in HIV-1-infected patients receiving nevirapine-containing antiretroviral therapy. AIDS (2001) 1.92
The natural history of human immunodeficiency virus infection in a haemophilic cohort. Br J Haematol (1989) 1.84
Current concepts in the assessment and treatment of hepatic encephalopathy. QJM (2009) 1.82
Hemolytic anemia in Wilson's disease. N Engl J Med (1967) 1.78
Conservation in vivo of protease cleavage sites in antigenic sites of poliovirus. J Gen Virol (1987) 1.76
Declaring independence: why we should be cautious. J Epidemiol Community Health (1990) 1.72
Evaluation of Roche Amplicor PCR assay for Mycobacterium tuberculosis. J Clin Microbiol (1996) 1.70
Human immunodeficiency virus (HIV) antibody avidity testing to identify recent infection in newly diagnosed HIV type 1 (HIV-1)-seropositive persons infected with diverse HIV-1 subtypes. J Clin Microbiol (2006) 1.64
Telephone reminders to reduce non-attendance rate for endoscopy. J R Soc Med (2003) 1.62
Intertypic genomic rearrangements of poliovirus strains in vaccinees. Virology (1988) 1.59
Clinicopathological investigation of primary, uncomplicated maedi-visna virus infection. Vet Rec (1992) 1.59
Access to medical care one year prior to diagnosis in 100 HIV-positive women. Fam Pract (1997) 1.59
Purification and properties of Escherichia coli dihydrofolate reductase. Biochemistry (1975) 1.57
Treatment of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments: experience in 26 cases. N Engl J Med (1982) 1.56
Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: a prospective cohort study. Lancet (2001) 1.55
Computer conferencing: the "nurse" in the "Electronic School District". Comput Nurs (1992) 1.51
Disease progression and survival in HIV-1-infected Africans in London. AIDS (1998) 1.47
Diurnal pattern of variceal bleeding in cirrhotic patients. J Hepatol (1993) 1.47
Pretreatment prognostic factors for children with hepatoblastoma-- results from the International Society of Paediatric Oncology (SIOP) study SIOPEL 1. Eur J Cancer (2000) 1.47
The temperature sensitivity of the Sabin type 3 vaccine strain of poliovirus: molecular and structural effects of a mutation in the capsid protein VP3. J Gen Virol (1989) 1.46
Responses to highly active antiretroviral therapy and clinical events in patients with a low CD4 cell count: late presenters vs. late starters. HIV Med (2010) 1.45
Can the prevalence of disease risk factors be assessed from general practice records? Br Med J (Clin Res Ed) (1986) 1.45
Cisplatin, doxorubicin, and delayed surgery for childhood hepatoblastoma: a successful approach--results of the first prospective study of the International Society of Pediatric Oncology. J Clin Oncol (2000) 1.44
Birth cohort, time, and age effects in Italian cancer mortality. Cancer (1987) 1.42
Measles immunisation rates and the good practice allowance. Br Med J (Clin Res Ed) (1986) 1.42
Serum proteins and mortality. Lancet (1990) 1.41
Survival differences in European patients with AIDS, 1979-89. The AIDS in Europe Study Group. BMJ (1994) 1.41
Experimental reduction of portal hypertension by mechanical increase of liver portal flow. Lancet (1991) 1.40
Staple-line erosion: a common source of recurrent bleeding following stapled oesophageal transection. Br J Surg (1991) 1.39
Federation of International Societies of Pediatric Gastroenterology, Hepatology, and Nutrition consensus report on celiac disease. J Pediatr Gastroenterol Nutr (2008) 1.38
LeVeen shunt with wandering tip. Lancet (1991) 1.36
Update on World Health Organization HIV drug resistance prevention and assessment strategy: 2004-2011. Clin Infect Dis (2012) 1.36
Prospective randomised trial of chemotherapy given before radiotherapy in childhood medulloblastoma. International Society of Paediatric Oncology (SIOP) and the (German) Society of Paediatric Oncology (GPO): SIOP II. Med Pediatr Oncol (1995) 1.34
An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-MY20) in assessing the quality of life of patients with multiple myeloma. Eur J Cancer (2007) 1.33
Tissue cytokine and chemokine expression in inflammatory bowel disease. Inflamm Res (2001) 1.33
Determinants of sustainable CD4 lymphocyte count increases in response to antiretroviral therapy. AIDS (1999) 1.33
Updated European recommendations for the clinical use of HIV drug resistance testing. Antivir Ther (2004) 1.28
Dual resistance to zidovudine and lamivudine in patients treated with zidovudine-lamivudine combination therapy: association with therapy failure. J Infect Dis (1998) 1.26
Acute renal disease, as defined by the RIFLE criteria, post-liver transplantation. Am J Transplant (2006) 1.25
Trends over calendar time in antiretroviral treatment success and failure in HIV clinic populations. HIV Med (2010) 1.23
Virological and immunological effects of treatment interruptions in HIV-1 infected patients with treatment failure. AIDS (2000) 1.23
Motivational effect of cholesterol measurement in general practice health checks. Br J Gen Pract (1992) 1.22
The pathophysiology of congenital chloridorrhoea. Q J Med (1973) 1.21
Randomised placebo controlled trial of nebulised corticosteroids in acute respiratory syncytial viral bronchiolitis. Arch Dis Child (2000) 1.21
Dimethylsulphoxide-induced toxicity. Lancet (1980) 1.20
Stimulation by glucagon of insulin release from rabbit pancreas in vitro. Lancet (1966) 1.20
Jaundice due to oxyphenisatin. Lancet (1971) 1.19
Cardiac beriberi: two modes of presentation. Br Med J (1971) 1.19
Maternal hepatotoxicity with nevirapine as part of combination antiretroviral therapy in pregnancy. HIV Med (2006) 1.19
Self-taken pharyngeal and rectal swabs are appropriate for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae in asymptomatic men who have sex with men. Sex Transm Infect (2008) 1.19
CD8+,CD38+ lymphocyte percent: a useful immunological marker for monitoring HIV-1-infected patients. J Acquir Immune Defic Syndr Hum Retrovirol (1997) 1.14
Pressure relieving support surfaces: a randomised evaluation. Health Technol Assess (2006) 1.14
Stabilization of poly-L-lysine/DNA polyplexes for in vivo gene delivery to the liver. Biochim Biophys Acta (1999) 1.14
Evaluation of HIV protease inhibitor use and the risk of sudden death or nonhemorrhagic stroke. J Infect Dis (2012) 1.13
Baseline cardiovascular risk in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial. HIV Med (2015) 1.11
Bleeding time in patients with hepatic cirrhosis. BMJ (1990) 1.10
Pathophysiology of post-gastrectomy hypoglycaemia. Br Med J (1969) 1.10
A comparison of sclerotherapy with staple transection of the esophagus for the emergency control of bleeding from esophageal varices. N Engl J Med (1989) 1.10
Severe pain confounds neuropsychological test performance. J Clin Exp Neuropsychol (2000) 1.10
Descriptive epidemiology of skin cancer in the Swiss Canton of Vaud. Int J Cancer (1988) 1.10
Why portal hypertensive varices bleed and bleed: a hypothesis. Gut (1995) 1.10
Virological response to protease inhibitor therapy in an HIV clinic cohort. AIDS (1999) 1.09
Early jaundice after open-heart surgery. Thorax (1967) 1.08
Traveller's diarrhoea with a vengeance in children of UK immigrants visiting their parental homeland. Arch Dis Child (1982) 1.08
The prevalence of hepatitis C virus (HCV) infection in HIV-positive individuals in the UK - trends in HCV testing and the impact of HCV on HIV treatment outcomes. J Viral Hepat (2009) 1.07
Disorders of the cytoskeleton of the enterocyte. Clin Gastroenterol (1986) 1.07
Assessing attention deficit hyperactivity disorder via quantitative electroencephalography: an initial validation study. Neuropsychology (1999) 1.06
Assessment of patellar maltracking using combined static and dynamic MRI. Eur Radiol (2000) 1.05
Flat small intestinal mucosa and autoantibodies against the gut epithelium. J Pediatr Gastroenterol Nutr (1982) 1.05